ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ledaga recommended by NICE for rare type of lymphoma
July 19, 2021The National Institute for Health and Care Excellence (NICE) has recommended Recordati Rare Diseases and Helsinn Healthcare’s Ledaga for a type of lymphoma that affects the skin. -
EC grants marketing authorisation for Actelion’s Ledaga to treat MF-CTCL
March 09, 2017The European Commission (EC) has granted marketing authorisation for 160mcg of Actelion’s Ledaga (chlormethine gel) to treat mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL).
Pharma Sources Insight January 2025
